IR is characterized by the subdued activation of the proximal insulin signaling cascade, particularly Akt, which in turn leads to deregulation of downstream targets, like GSK3, PRAS40, Foxo1, and, consequently, the inability to downregulate gluconeogenesis during NAFLD. The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatotic liver disease.